Peter W. Payne

490 total citations
15 papers, 378 citations indexed

About

Peter W. Payne is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Peter W. Payne has authored 15 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Peter W. Payne's work include Cancer Genomics and Diagnostics (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Cervical Cancer and HPV Research (3 papers). Peter W. Payne is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Cervical Cancer and HPV Research (3 papers). Peter W. Payne collaborates with scholars based in Canada, United States and Japan. Peter W. Payne's co-authors include Branko Palcic, Stephen Lam, Jean LeRiche, David M. Garner, Calum MacAulay, Luc Thiberville, Douglas E. Horsman, G Nouvet, Thomas J. Sebo and Mladen Korbelik and has published in prestigious journals such as Mayo Clinic Proceedings, Human Pathology and Photochemistry and Photobiology.

In The Last Decade

Peter W. Payne

14 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter W. Payne Canada	9	201	104	92	78	75	15	378
Phillipe Taniere United Kingdom	12	98 0.5×	96 0.9×	112 1.2×	62 0.8×	65 0.9×	24	285
Richard P. Saunders United States	5	280 1.4×	103 1.0×	123 1.3×	86 1.1×	51 0.7×	7	466
Beata Biesaga Poland	12	114 0.6×	130 1.3×	127 1.4×	103 1.3×	59 0.8×	43	392
Chien‐An Liu Taiwan	12	172 0.9×	66 0.6×	107 1.2×	78 1.0×	117 1.6×	34	481
K. Shimada Japan	9	123 0.6×	101 1.0×	160 1.7×	45 0.6×	112 1.5×	28	351
Andrea Arenz Germany	11	112 0.6×	184 1.8×	120 1.3×	85 1.1×	37 0.5×	22	411
Tao‐Lan Zhang China	14	103 0.5×	143 1.4×	62 0.7×	80 1.0×	43 0.6×	37	389
Jose J. Galvez United States	9	90 0.4×	179 1.7×	128 1.4×	58 0.7×	23 0.3×	16	351
Suresh Ramalingam United States	6	257 1.3×	90 0.9×	136 1.5×	40 0.5×	81 1.1×	18	404
Anna Paterson United Kingdom	13	101 0.5×	92 0.9×	92 1.0×	40 0.5×	131 1.7×	40	336

Countries citing papers authored by Peter W. Payne

Since Specialization

Citations

This map shows the geographic impact of Peter W. Payne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Payne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Payne more than expected).

Fields of papers citing papers by Peter W. Payne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Payne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Payne. The network helps show where Peter W. Payne may publish in the future.

Co-authorship network of co-authors of Peter W. Payne

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Payne. A scholar is included among the top collaborators of Peter W. Payne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Payne. Peter W. Payne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Payne, Peter W.. (2014). Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?. The Pharmacogenomics Journal. 14(5). 473–480. 10 indexed citations

Payne, Peter W.. (2009). Cytometric detection of nuclear features associated with pre-malignancy or malignancy in human bronchial specimens. Open Collections.

Korbelik, Mladen, et al.. (2006). Acute phase response induced following tumor treatment by photodynamic therapy: relevance for the therapy outcome. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6087. 60870C–60870C. 8 indexed citations

Korbelik, Mladen, Jinghai Sun, & Peter W. Payne. (2003). Activation of Poly(adenosine diphosphate-ribose) Polymerase in Mouse Tumors Treated by Photodynamic Therapy¶. Photochemistry and Photobiology. 78(4). 400–400. 8 indexed citations

Palcic, Branko, et al.. (2002). Increase of sensitivity of sputum cytology using high‐resolution image cytometry: Field study results. Cytometry. 50(3). 168–176. 40 indexed citations

Payne, Peter W., et al.. (1999). O35. Estimation of time since death by image cytometric analysis of cell nuclei. Journal of Clinical Forensic Medicine. 6(3). 197–198. 1 indexed citations

MacAulay, Calum, Stephen Lam, Jean LeRiche, et al.. (1998). Malignancy associated changes in bronchial epithelial cells and clinical application as a biomarker. Lung Cancer. 19(3). 161–166. 33 indexed citations

MacAulay, Calum, Stephen Lam, Adi F. Gazdar, et al.. (1998). <title>Intermediate endpoint biomarkers for lung cancer chemoprevention</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3260. 207–211. 1 indexed citations

Thiberville, Luc, Peter W. Payne, J Métayer, et al.. (1997). Molecular follow-up of a preinvasive bronchial lesion treated by 13-CIS-retinoic acid. Human Pathology. 28(1). 108–110. 6 indexed citations

10.

Payne, Peter W., Thomas J. Sebo, David M. Garner, et al.. (1997). Sputum screening by quantitative microscopy: a reexamination of a portion of the National Cancer Institute Cooperative Early Lung Cancer Study.. Mayo Clinic Proceedings. 72(8). 697–704. 53 indexed citations

11.

Payne, Peter W., Thomas J. Sebo, David M. Garner, et al.. (1997). Sputum Screening by Quantitative Microscopy A Reexamination of a Portion of the National Cancer Institute Cooperative Early Lung Cancer Study. Mayo Clinic Proceedings. 72(8). 697–704. 31 indexed citations

12.

Thiberville, Luc, Peter W. Payne, Jean LeRiche, et al.. (1996). Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Lung Cancer. 14(2-3). 382–383. 146 indexed citations

13.

Ikeda, Norihiko, Calum MacAulay, Stéphanie Lam, et al.. (1995). Use of high-resolution cytometry in predicting the biologic behavior of T1 adenocarcinoma of the lung. Lung Cancer. 13(1). 92–92. 3 indexed citations

14.

Ferris, Daron G., et al.. (1993). Cervicography: adjunctive cervical cancer screening by primary care clinicians.. PubMed. 37(2). 158–64. 24 indexed citations

15.

Payne, Peter W., et al.. (1993). Cervicography: an intermediate triage test for the evaluation of cervical atypia.. PubMed. 37(5). 463–8. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact